Improving the Effectiveness of FDA Drug Inspection

The evaluation and the allocation of inspection resources is a problem faced by private sector firms as well as by several government agencies. This paper reports the development and the use by the Food and Drug Administration (FDA) of decision making tools for measuring the performance of their dru...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Operations research Jg. 40; H. 5; S. 845 - 855
Hauptverfasser: Klimberg, Ronald, Revelle, Charles, Cohon, Jared
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Linthicum, MD INFORMS 01.09.1992
Operations Research Society of America
Institute for Operations Research and the Management Sciences
Schlagworte:
agencies: regulating inspections
Biological and medical sciences
Case studies
data analysis: multiple logistic regression and index
decomposed and heuristics
Drug design
Drug regulation
Federal regulation
government
Government agencies
Health and social institutions
Heuristics
Industrial regulation
Inspections
Integer programming
Mathematical models
Medical sciences
Medication adherence
multiple criteria: multiobjective integer program
OR Practice
Pharmaceutical industries
Pharmaceutical industry
Probabilities
programming
Public health. Hygiene
Public health. Hygiene-occupational medicine
Statistics
Surveillance
Tradeoffs
United States
North America
America
United States > US
Health system
Resource repartition
Supervisory institution
Public health organization
Decision aid
Models
Pharmaceutical industry
Food and Drug Administration
Public health
ISSN:0030-364X, 1526-5463
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The evaluation and the allocation of inspection resources is a problem faced by private sector firms as well as by several government agencies. This paper reports the development and the use by the Food and Drug Administration (FDA) of decision making tools for measuring the performance of their drug inspection activities in which data are collected only intermittently, and a multiobjective integer program to assist FDA decision makers in planning and evaluating the effectiveness of their drug inspection activities.
Bibliographie:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ISSN:0030-364X
1526-5463
DOI:10.1287/opre.40.5.845